Peyer James 13D and 13G filings for Sensei Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 5:16 pm Purchase | 2022-12-31 | 13G | Sensei Biotherapeutics, Inc. SNSE | Peyer James | 5,235,956 17.000% | 5,235,956 (New Position) | Filing |
| 2021-02-16 10:59 am Purchase | 2021-02-03 | 13G | Sensei Biotherapeutics, Inc. SNSE | Peyer James | 4,690,153 15.300% | 4,690,153 (New Position) | Filing |